Search

everythinglearnresearchcommunity

for

Search:↓

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Steroid-binding globulins have important roles beyond just transporting steroids.

Mutations in certain receptors can cause diseases and offer new treatment options.

Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.

PEA boosts allopregnanolone production and reduces oxidative stress in brain cells.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Steroid cell tumors in ovaries are rare, can cause hormone changes, and may be cancerous.

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

A simple and eco-friendly method was developed to make finasteride Form-I using water.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

Estazolam reduces anxiety-like behavior in PTSD by increasing allopregnanolone levels.

Heart-specific steroid metabolism is crucial in cardiac hypertrophy.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The steroids allopregnanolone and allotetrahydrodeoxycorticosteron worsened absence seizures in rats.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Enzyme activities do not cause early pubic hair in these girls.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.